logo
logo

Ventus Therapeutics Closes $100 Million Series B Financing

Ventus Therapeutics Closes $100 Million Series B Financing

04/08/21, 10:06 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgwaltham
Money raised
$100 million
Round Type
series b
Ventus Therapeutics, Inc., a biotechnology company utilizing rational structure-based drug design to discover small-molecule medicines for high value and elusive targets, today announced a $100 million Series B financing led by RA Capital Management with participation from a select syndicate including BVF Partners L.P., Casdin Capital, Cormorant Asset Management, Fonds de solidariteĢ FTQ, and Alexandria Venture Investments. Founding investor Versant Ventures also participated in the round, as did existing investor GV (formerly Google Ventures).

Company Info

Company
Ventus Therapeutics
Location
waltham, massachusetts, united states
Additional Info
Ventus Therapeutics is a biopharmaceutical company utilizing structural biology and computational tools to identify and develop small molecule therapeutics across a broad range of disease indications, with an initial focus on immunology, inflammation and neurology. We have developed a proprietary drug discovery platform, called ReSOLVE, which is built upon our structural biology and protein science expertise and our proprietary computational chemistry capabilities, to address the current limitations of small molecule drug discovery. We are leveraging our ReSOLVE platform to discover and characterize previously unknown or poorly understood pockets on the surface of proteins and identify small molecules that can bind to those pockets with optimal affinity. We are focused on high-value targets that have been extensively implicated in human diseases that were previously considered undruggable or where we believe there is a significant opportunity to improve upon existing therapies. Our lead programs target key innate immune modulators, including NLRP3 and cGAS. For more information, please visit www.ventustx.com and engage with us on Twitter @Ventus_Tx or on LinkedIn.